EDGAR Filing Documents for 0001209191-13-051498

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-13-051498

Filing Date

2013-11-12

Accepted

2013-11-12 07:35:53

Documents

Period of Report

2013-11-08

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	3669
	Complete submission text file	0001209191-13-051498.txt		5737

Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121

Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700

Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137

Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015

Opko Health, Inc. (Reporting) CIK: 0000944809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 131206973
SIC: 2834 Pharmaceutical Preparations